Cetuximab in Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Ovarian Cancer Without KRAS, NRAS, or BRAF Mutations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Fisher, Julie G., Tait, David, Garrett-Mayer, Elizabeth, Halabi, Susan, Mangat, Pam K., Schink, Julian C., Alvarez, Ricardo H., Veljovich, Dan, Cannon, Timothy L., Crilley, Pamela A., Pollock, Theodore, Calfa, Carmen J., Al Baghdadi, Tareq, Thota, Ramya, Fleming, Nicole, Cotta, Jared A., Rygiel, Andrew L., Warren, Sasha L., Schilsky, Richard L.
Published in Targeted oncology (01.12.2020)
Published in Targeted oncology (01.12.2020)
Get full text
Journal Article
Cobimetinib plus gemcitabine is an active combination in KRAS G12R-mutated in previously chemotherapy-treated and failed pancreatic patients
Ardalan, Bach, Cotta, Jared Addison, Gombosh, Miriam, Azqueta, Jose Ignacio
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Evolution of precision oncology treatment options over time
Gordon, Bat-Ami, Cotta, Jared, Trent, Jonathan C.
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Exploring racial disparities of actionable mutations in gynecologic cancers
Jhaveri, Vasanti, Fanfan, Dino, Cotta, Jared Addison, George, Sophia, Slomovitz, Brian M., Huang, Marilyn
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Utility of Circulating Tumor DNA in the Management of Patients With GI Stromal Tumor: Analysis of 243 Patients
Arshad, Junaid, Roberts, Ali, Ahmed, Jibran, Cotta, Jared, Pico, Brian A, Kwon, Deukoo, Trent, Jonathan C
Published in JCO precision oncology (01.11.2020)
Published in JCO precision oncology (01.11.2020)
Get more information
Journal Article
Abstract CT135: Cetuximab (C) in patients (Pts) with breast cancer (BC) and non-small cell lung cancer (NSCLC) without reported KRAS, NRAS, BRAF mutations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Fisher, Julie, Garrett-Mayer, Elizabeth, Halabi, Susan, Mangat, Pam K., Alvarez, Ricardo H., Cannon, Timothy L., Crilley, Pamela, Pollock, Theodore, Baghdadi, Tareq Al, Cotta, Jared A., Rygiel, Andrew L., Antonelli, Kaitlyn R., Islam, Samiha, Bruinooge, Suanna S., Schilsky, Richard L.
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Get full text
Journal Article
Successful automated normalization of cancer outcomes for half a million patients across four disparate health systems
Tittel, Paul D., Zaman, Ali, Shima, James E., Leal, David, Chen, James Lin, Ghosh, Aradhana, Hirsch, Jonathan, Trent, Jonathan C., Gordon, Bat-Ami, Cotta, Jared, Thompson, Michael A., Godden, Jennifer, Ruggeri, Antony, Weese, James Leighton, Haque, Nadia Z, Hoover, Spencer C., Kalkanis, Steven N.
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article